Skip to content

Clinical trials

Phase 2 Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2 Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20036
20045
20054
20066
20075
20085
20096
20103
20114
20125
20134
20145
20157
20163
20172
20184
20192
20205
20212
20225
20234
20243
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Unknown status17
Terminated12
Recruiting6
Withdrawn5
Not yet recruiting4
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amaranth Medical Inc.4
AstraZeneca3
University Health Network, Toronto3
Bayer2
Hospices Civils de Lyon2
Jun Li2
Meshalkin Research Institute of Pathology of Circulation2
Mesoblast, Inc.2
Oslo University Hospital2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction110
Coronary Artery Disease17
Myocardial Ischemia17
ST Elevation Myocardial Infarction15
Acute Coronary Syndrome12
Cardiovascular Diseases12
Heart Failure11
Heart Diseases10
Coronary Disease9
Angina Pectoris7

Trials

Showing 51 to 75 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.